Health

AACR 2023 | Ascentage Pharma Presents Results from Three Studies Underscoring Exploratory Efforts in Potential New Indications

SUZHOU, China and ROCKVILLE, Md., April 17, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it had released results from three preclinic...

2023-04-18 09:08 1689

GC Biopharma celebrates 'World Hemophilia Day'

* To display a large media façade on its Yong-in R&D Center YONGIN, South Korea, April 17, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, takes part in a campaign to celebrate World Hemophilia Day. The company announced that a l...

2023-04-18 09:03 1645

USANA Malaysia Donates MYR 40,000 to Local Flood Relief

Donation in partnership with Suriana Welfare Society Malaysia KUALA LUMPUR, Malaysia, April 18, 2023 /PRNewswire/ -- Heavy flooding in Johor has led USANA Malaysia to donateMYR 40,000 in relief funds for those affected by this natural disaster. Beyond this donation, the company and its Associates...

2023-04-18 08:24 2002

Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-18 08:00 2189

Promising Efficacy of AT101 CAR-T for Blood Cancer

SEOUL, South Korea, April 17, 2023 /PRNewswire/ -- AbClon, a South Korean biotech firm, presented non-clinical and phase 1 interim results of its AT101 novel CAR-T therapy at the annual 2023 AACR conference. AT101 targets the CD19 protein for treatment of blood cancer. AT101 demonstrated superio...

2023-04-18 02:00 1670

Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2022

BEIJING, April 17, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ende...

2023-04-17 20:24 2457

Orion Health launches Orchestral - a once in a generation giant leap forward for health data

Orchestral reimagines the aggregation of data and how it is used in healthcare in the modern machine learning era. AUCKLAND, New Zealand, April 17, 2023 /PRNewswire/ -- The Orchestral health intelligence platform, announced at HIMSS23, is the biggest step forward in health data since the advent ...

2023-04-17 20:00 1768

Asieris Releases 2022 Annual Report: Makes Steady Progress in its Clinical Development, Global Expansion to Treat Genitourinary Tumors, and Implementing its Commercialization Strategy to Provide Integrated Diagnosis-to-Treatment Solutions

SHANGHAI, April 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in the discovery, development and commercialization of innovative drugs that treat genitourinary (GU) tumors and other related diseases, today released its 2022 annual report. Whil...

2023-04-17 18:30 1934

Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development

TAIPEI, April 17, 2023 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announces today thatBassem Elmankabadi, M.D. joins Foresee as a Senior Vice President of Clinical Development. Dr. Bassem Elmankabadi is a Board Certified Surgeon with over 17 years of clinical backg...

2023-04-17 16:50 1654

Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 16, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-17 08:20 3106

Introducing the MetaSight® G200: A Revolutionary Third-Generation Chromosomal Karyotyping System Transforming Global Chromosomal Analysis

CHANGSHA, China, April 15, 2023 /PRNewswire/ -- The MetaSight® G200 is a groundbreaking karyotyping system based on high-resolution microscopy technology, capable of accurately detecting chromosomal abnormalities in humans. This innovative system aids doctors in diagnosing and treating diseases ...

2023-04-15 14:43 3116

Meihua International Medical Technologies Co., Ltd. Reports 2022 Financial Year Results

YANGZHOU, China, April 14, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its financial r...

2023-04-14 20:45 3949

Minghui Pharmaceutical Inc. Announces Phase 2 Clinical Trial Success of MH004 Cream as a Potential Best-in-Class Topical Treatment for Mild-to-Moderate Atopic Dermatitis and the FDA Clearance of its Global Phase 3 MRCT

* Study met both primary and all key secondary endpoints * Mean percentage change from baseline in Eczema Area and Severity Index (EASI) score was -78.7% in 1.0% MH004 Cream-treated group compared to -46.7% in vehicle group * 79.6% individuals treated with 1.0% MH004 Cream achieved EASI-75 c...

2023-04-14 19:00 6493

Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults

NANJING, China, April 13, 2023 /PRNewswire/ -- On April 1st, 2023, during the First Infection Collaboration Forum of the Chinese National Center for Infectious Diseases, Nanjing Zenshine Pharmaceuticals Co., Ltd. (Zenshine Pharmaceuticals) announced that its proprietary anti-influenza agent ZX-71...

2023-04-14 01:15 1984

Healint and King's College London Announce a Ground-breaking Study on the Interaction between Sleep and Migraine in a Large Global Sample

PALO ALTO, Calif., April 13, 2023 /PRNewswire/ -- Healint, a digital health company specializing in Central Nervous System disease management has partnered with King's College London to conduct a ground-breaking study on the relationship between sleep and migraine. The study, which collected anon...

2023-04-13 20:00 1507

Viva Biotech Attended SAPA-China

HONG KONG, April 12, 2023 /PRNewswire/ -- 6th-7th April, the "2022 SAPA-China Annual Conference - Opportunities and Challenges for the Development ofChina's Biopharmaceutical Industry" hosted by The Sino-American Pharmaceutical Professionals Association (SAPA) was held inChengdu, Sichuan. Viva Bi...

2023-04-13 11:33 2247

Smart Physiotherapy Systems: One-Stop Solution for Pain Patients

WUHAN, China, April 12, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic and physiotherapy markets based inWuhan and Dusseldorf, reported the great improvement of Smart Physiotherapy Systems that were launched several ...

2023-04-13 11:10 1736

Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea and CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis, cancer, and inflammation, announced it has dosed the first patient in its Phase 2a clinical study...

2023-04-13 06:00 1857

Standigm announces Younsung Choo as chief executive officer

Former LG life Sciences exec and long-time Standigm advisor brings extensive experience in pharmaceuticals and project management SEOUL, South Korea, April 12, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discover...

2023-04-13 00:07 2059

Health In Tech Partners With 6 Degrees Health to Accelerate Implementation of Level-Funded Health Plans with Transparency, Control, and Predictability

Brokers and Employers with groups ranging from 5-150 lives will benefit from the partnership's fully integrated, solution-based products for the level-funded healthcare market. STUART, Fla., April 12, 2023 /PRNewswire/ -- Health in Tech ("HIT", or "the Company"), the industry-leading insurtech c...

2023-04-12 20:30 1753
1 ... 103104105106107108109 ... 280